These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 7969039
41. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38. Yang JS, Hour MJ, Kuo SC, Huang LJ, Lee MR. Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354 [Abstract] [Full Text] [Related]
43. Transcription factor c-Jun activation represses mdr-1 gene expression. Miao ZH, Ding J. Cancer Res; 2003 Aug 01; 63(15):4527-32. PubMed ID: 12907627 [Abstract] [Full Text] [Related]
44. Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro. Liu JJ, Huang RW, Lin DJ, Wu XY, Lin Q, Peng J, Pan X, Song YQ, Zhang MH, Hou M, Chen F. Oncol Rep; 2005 Apr 01; 13(4):653-7. PubMed ID: 15756438 [Abstract] [Full Text] [Related]
45. [Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells]. Song Y, Yuan SL, Yang YM, Wang XJ, Huang GQ. Zhongguo Zhong Yao Za Zhi; 2005 Feb 01; 30(3):207-11. PubMed ID: 15719642 [Abstract] [Full Text] [Related]
46. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis. Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L. Cell Death Differ; 1998 Sep 01; 5(9):735-42. PubMed ID: 10200532 [Abstract] [Full Text] [Related]
47. [Effect of (-)-epigallocatechin-3-gallate and 5-AZA-CdR on expression of X-linked inhibitor of apoptosis protein-associated factor 1 in human leukemia HL-60 and K562 cells]. Huang YY, Xia Y, Guo HX, Li WY. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb 01; 28(2):204-8. PubMed ID: 18250043 [Abstract] [Full Text] [Related]
48. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL. Mc Gee MM, Greene LM, Ledwidge S, Campiani G, Nacci V, Lawler M, Williams DC, Zisterer DM. J Pharmacol Exp Ther; 2004 Sep 01; 310(3):1084-95. PubMed ID: 15143129 [Abstract] [Full Text] [Related]
49. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells. Kamath N, Grabowski D, Ford J, Drake F, Kerrigan D, Pommier Y, Ganapathi R. Cancer Commun; 1991 Feb 01; 3(2):37-44. PubMed ID: 1995027 [Abstract] [Full Text] [Related]
50. [The mechanism of apoptosis induced by anticancer agents in human leukemia HL-60 cells]. Yoshida A, Ueda T, Nakamura T. Rinsho Ketsueki; 1996 Jul 01; 37(7):552-7. PubMed ID: 8779771 [Abstract] [Full Text] [Related]
51. Mechanism of apoptosis induced by cisplatin and VP-16 in PANC-1 cells. Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K, Miyamoto Y, Mori C, Nakamura N, Shiota K, Imamura M. Anticancer Res; 1997 Jul 01; 17(5A):3445-50. PubMed ID: 9413185 [Abstract] [Full Text] [Related]
52. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Kaufmann SH. Cancer Res; 1989 Nov 01; 49(21):5870-8. PubMed ID: 2790800 [Abstract] [Full Text] [Related]
53. Multidrug resistance due to impaired DNA cleavage in a VP-16-resistant human leukemia cell line. Fukushima T, Takemura H, Yamashita T, Ishisaka T, Inai K, Imamura S, Urasaki Y, Ueda T. Anticancer Res; 1999 Nov 01; 19(6B):5111-5. PubMed ID: 10697518 [Abstract] [Full Text] [Related]
54. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells. Kim BM, Choi YJ, Han Y, Yun YS, Hong SH. Toxicol Appl Pharmacol; 2009 Aug 15; 239(1):87-97. PubMed ID: 19481559 [Abstract] [Full Text] [Related]
55. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells. Nagata T, Higashigawa M, Shimono Y, Cao DC, Yan Mao X, M'soka T, Inamochi H, Hori H, Kawasaki H, Sakurai M. J Exp Clin Cancer Res; 1998 Dec 15; 17(4):435-42. PubMed ID: 10089064 [Abstract] [Full Text] [Related]
56. Apoptosis induced by DNA primase inhibitor 3,3'-diethyl-9-methylthia-carbocyanine iodide in human leukemia HL-60 cells. Li ZM, Jiang WQ, Guan ZZ, Zhu XF, Zhou JM, Xie BF, Feng GK, Zhu ZY, Liu ZC. Yao Xue Xue Bao; 2006 Oct 15; 41(10):978-84. PubMed ID: 17184117 [Abstract] [Full Text] [Related]
57. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Guo F, Rocha K, Bali P, Pranpat M, Fiskus W, Boyapalle S, Kumaraswamy S, Balasis M, Greedy B, Armitage ES, Lawrence N, Bhalla K. Cancer Res; 2005 Nov 15; 65(22):10536-44. PubMed ID: 16288046 [Abstract] [Full Text] [Related]
58. Altered gene expression in human leukemia K562 cells selected for resistance to etoposide. Ritke MK, Yalowich JC. Biochem Pharmacol; 1993 Dec 03; 46(11):2007-20. PubMed ID: 8267650 [Abstract] [Full Text] [Related]
59. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro. Yalowich JC. Cancer Res; 1987 Feb 15; 47(4):1010-5. PubMed ID: 2879622 [Abstract] [Full Text] [Related]
60. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW, Weichselbaum RR. Cancer Res; 1995 Mar 01; 55(5):991-4. PubMed ID: 7867010 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]